Frequency of diagnosis of cancer or high-risk lesion at operation for pathologic nipple discharge

Sean C. Dupont, Judy C Boughey, Rafael E Jimenez, Tanya L. Hoskin, Tina J Hieken

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background Pathologic nipple discharge is managed customarily with diagnostic subareolar duct excision. We evaluated for features predictive of malignancy to identify cases where operation might be avoided. Methods We studied 311 consecutive subareolar duct excisions for pathologic nipple discharge from January 2008 to July 2014. χ<sup>2</sup> tests were used to test for associations with final pathology. Results In 27 cases, cancer was diagnosed preoperatively. Among the remaining 284, 26 (9%) were diagnosed with cancer and 8 (3%) with atypia at operation. At greatest risk of upstage to cancer were patients with prior ipsilateral breast cancer (3/8; 38%), BRCA mutation (2/3; 67%) or atypia on core needle biopsy (CNB; 3/8 [38%]). Excluding these patients lowered cancer and atypia upstages (7% [18/265] and 3% [7/265]), with bloody (versus serous) discharge (P =.001), and focal imaging abnormality (P =.02), the strongest risk factors. Serous discharge and either normal imaging or a benign CNB had a 1.3% cancer upstage rate. Conclusion Despite contemporary imaging, pathologic nipple discharge upstage rates to malignancy and atypia remain high, especially with prior ipsilateral breast cancer, BRCA mutation, or atypia on CNB. Absent these risk factors, patients with serous discharge and a benign CNB or normal imaging (cancer risk <2%) may be considered for nonoperative management.

Original languageEnglish (US)
Pages (from-to)988-995
Number of pages8
JournalSurgery (United States)
Volume158
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Neoplasms
Large-Core Needle Biopsy
Mutation
Nipple Discharge
Pathology
Breast Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Frequency of diagnosis of cancer or high-risk lesion at operation for pathologic nipple discharge. / Dupont, Sean C.; Boughey, Judy C; Jimenez, Rafael E; Hoskin, Tanya L.; Hieken, Tina J.

In: Surgery (United States), Vol. 158, No. 4, 01.10.2015, p. 988-995.

Research output: Contribution to journalArticle

@article{290e473ef10b4c3799d7860fcf182d1d,
title = "Frequency of diagnosis of cancer or high-risk lesion at operation for pathologic nipple discharge",
abstract = "Background Pathologic nipple discharge is managed customarily with diagnostic subareolar duct excision. We evaluated for features predictive of malignancy to identify cases where operation might be avoided. Methods We studied 311 consecutive subareolar duct excisions for pathologic nipple discharge from January 2008 to July 2014. χ2 tests were used to test for associations with final pathology. Results In 27 cases, cancer was diagnosed preoperatively. Among the remaining 284, 26 (9{\%}) were diagnosed with cancer and 8 (3{\%}) with atypia at operation. At greatest risk of upstage to cancer were patients with prior ipsilateral breast cancer (3/8; 38{\%}), BRCA mutation (2/3; 67{\%}) or atypia on core needle biopsy (CNB; 3/8 [38{\%}]). Excluding these patients lowered cancer and atypia upstages (7{\%} [18/265] and 3{\%} [7/265]), with bloody (versus serous) discharge (P =.001), and focal imaging abnormality (P =.02), the strongest risk factors. Serous discharge and either normal imaging or a benign CNB had a 1.3{\%} cancer upstage rate. Conclusion Despite contemporary imaging, pathologic nipple discharge upstage rates to malignancy and atypia remain high, especially with prior ipsilateral breast cancer, BRCA mutation, or atypia on CNB. Absent these risk factors, patients with serous discharge and a benign CNB or normal imaging (cancer risk <2{\%}) may be considered for nonoperative management.",
author = "Dupont, {Sean C.} and Boughey, {Judy C} and Jimenez, {Rafael E} and Hoskin, {Tanya L.} and Hieken, {Tina J}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.surg.2015.05.020",
language = "English (US)",
volume = "158",
pages = "988--995",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Frequency of diagnosis of cancer or high-risk lesion at operation for pathologic nipple discharge

AU - Dupont, Sean C.

AU - Boughey, Judy C

AU - Jimenez, Rafael E

AU - Hoskin, Tanya L.

AU - Hieken, Tina J

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background Pathologic nipple discharge is managed customarily with diagnostic subareolar duct excision. We evaluated for features predictive of malignancy to identify cases where operation might be avoided. Methods We studied 311 consecutive subareolar duct excisions for pathologic nipple discharge from January 2008 to July 2014. χ2 tests were used to test for associations with final pathology. Results In 27 cases, cancer was diagnosed preoperatively. Among the remaining 284, 26 (9%) were diagnosed with cancer and 8 (3%) with atypia at operation. At greatest risk of upstage to cancer were patients with prior ipsilateral breast cancer (3/8; 38%), BRCA mutation (2/3; 67%) or atypia on core needle biopsy (CNB; 3/8 [38%]). Excluding these patients lowered cancer and atypia upstages (7% [18/265] and 3% [7/265]), with bloody (versus serous) discharge (P =.001), and focal imaging abnormality (P =.02), the strongest risk factors. Serous discharge and either normal imaging or a benign CNB had a 1.3% cancer upstage rate. Conclusion Despite contemporary imaging, pathologic nipple discharge upstage rates to malignancy and atypia remain high, especially with prior ipsilateral breast cancer, BRCA mutation, or atypia on CNB. Absent these risk factors, patients with serous discharge and a benign CNB or normal imaging (cancer risk <2%) may be considered for nonoperative management.

AB - Background Pathologic nipple discharge is managed customarily with diagnostic subareolar duct excision. We evaluated for features predictive of malignancy to identify cases where operation might be avoided. Methods We studied 311 consecutive subareolar duct excisions for pathologic nipple discharge from January 2008 to July 2014. χ2 tests were used to test for associations with final pathology. Results In 27 cases, cancer was diagnosed preoperatively. Among the remaining 284, 26 (9%) were diagnosed with cancer and 8 (3%) with atypia at operation. At greatest risk of upstage to cancer were patients with prior ipsilateral breast cancer (3/8; 38%), BRCA mutation (2/3; 67%) or atypia on core needle biopsy (CNB; 3/8 [38%]). Excluding these patients lowered cancer and atypia upstages (7% [18/265] and 3% [7/265]), with bloody (versus serous) discharge (P =.001), and focal imaging abnormality (P =.02), the strongest risk factors. Serous discharge and either normal imaging or a benign CNB had a 1.3% cancer upstage rate. Conclusion Despite contemporary imaging, pathologic nipple discharge upstage rates to malignancy and atypia remain high, especially with prior ipsilateral breast cancer, BRCA mutation, or atypia on CNB. Absent these risk factors, patients with serous discharge and a benign CNB or normal imaging (cancer risk <2%) may be considered for nonoperative management.

UR - http://www.scopus.com/inward/record.url?scp=84940787619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940787619&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2015.05.020

DO - 10.1016/j.surg.2015.05.020

M3 - Article

C2 - 26243343

AN - SCOPUS:84940787619

VL - 158

SP - 988

EP - 995

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 4

ER -